missing translation for 'onlineSavingsMsg'
Learn More

TCS 2312, Tocris Bioscience™
GREENER_CHOICE

Product Code. 18034232
Click to view available options
Quantity:
1 mg
Unit Size:
1mg
This item is not returnable. View return policy

Product Code. 18034232

Brand: Tocris Bioscience 3038/1

Please to purchase this item. Need a web account? Register with us today!

This item is currently unavailable or has been discontinued.
View the product page for possible alternatives.
View alternative products

This item is not returnable. View return policy

Potent Chk1 inhibitor

Potent and selective checkpoint kinase 1 (chk1) inhibitor (Ki = 0.38 nM, EC50 = 60 nM). Enhances the cell killing activity of Gemcitabine (Cat. No. 3259) in breast and prostate cancer cell lines and displays antiproliferative effects in vitro.
TRUSTED_SUSTAINABILITY

Specifications

CAS 838823-31-7
Molecular Formula C25H24N4O2
Quantity 1 mg
Synonym 4'-5-3-cyclopropylamino methyl phenyl amino-1h-pyrazol-3-yl-1,1'-biphenyl-2,4-diol, 4-5-4-cyclopropylaminomethyl-phenylamino-2h-pyrazol-3-yl-biphenyl-2,4-diol, tc0
InChI Key BYFCMDWKTJJQGR-UHFFFAOYSA-N
SMILES C1CC1NCC2=CC=C(C=C2)NC3=CC(=C4C=CC(=C5C=CC(=O)C=C5O)C=C4)NN3
IUPAC Name 4-[4-[5-[4-[(cyclopropylamino)methyl]anilino]-1,2-dihydropyrazol-3-ylidene]cyclohexa-2,5-dien-1-ylidene]-3-hydroxycyclohexa-2,5-dien-1-one
Molecular Weight (g/mol) 412.493
PubChem CID 11258443
Formula Weight 412.48
Percent Purity >97%
Chemical Name or Material TCS 2312
Show More Show Less
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.